Navigation Links
NCPA Endorses U.S. Senator Norm Coleman for Re-Election
Date:10/8/2008

ALEXANDRIA, Va., Oct, 8 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) is endorsing Sen. Norm Coleman (R-MN), a one-term incumbent representing Minnesota, for re-election to the U.S. Senate. Bruce Roberts, RPh, executive vice president and CEO of NCPA, issued the following statement:

"Senator Norm Coleman is a powerful advocate for Minnesota and America's community pharmacies and the patients they serve. That is why the National Community Pharmacists Association strongly endorses him for re-election to the U.S. Senate."

"Sen. Coleman is a proven leader in Minnesota, who recognizes the importance of bolstering healthcare resources for his constituents. We encourage the voters in his state to make the wise choice and return him to the Senate again with their votes on November 4th."

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. SEIU Endorses AB 8, An Opportunity to Make History
2. Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal
3. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
4. SEIU Endorses Anderson, Perea, and Perea in Fresno
5. Long-Time San Diego Community Leader, Transplant Patient, Joe Dolphin, Endorses John Mccain
6. The Childrens Aid Society Endorses Critical Components of Governor Spitzers Proposed 2008-2009 State Budget
7. The American Nurses Association Endorses Senator Hillary Rodham Clinton (D-NY)
8. National Lt. Governors Association Endorses HERO Campaign; 1st National Association of State Elected Officials Supporting Grassroots Designated Driving Program
9. National Business Coalition on Health Endorses Patient Charter for Physician Performance Measurement
10. AHIP Endorses Patient Charter to Guide Physician Performance Measurement, Reporting
11. National Union Hospital Healthcare Employees District 1199c Endorses Senator Obama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... KICKICO , a protocol built on ... to solve many catastrophic issues within funding campaigns. KICKICO developers are testing the platform, ... crowdfunding - the raising of funds through the power of many - has been ...
(Date:6/25/2017)... (PRWEB) , ... June 25, 2017 , ... FCPX LUT ... into an old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different color-grade ... grain for distorted looks, vignettes and blurs to single out subjects, plus much more. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... Republicans in the ... and replace Obamacare, called the Better Care Reconciliation Act. It differs significantly from the ... will need to be reconciled in committee, or the House will have to take ...
(Date:6/25/2017)... (PRWEB) , ... June 25, 2017 , ... CareSet Labs ... in New Orleans. This is a new, greatly improved version of the Doctor ... Act (FOIA) requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” ...
(Date:6/25/2017)... ... 25, 2017 , ... June is Men’s Health Month and the focus is on ... men in the U.S. and the third most common cause of cancer related death today; ... in seven will be diagnosed with prostate cancer during his lifetime. Those at highest ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... TEL AVIV, Israel , May 30, 2017 /PRNewswire/ ... clinical stage pharmaceutical Company specializing in the development ... management will present a company overview at three ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: